Johnson & Johnson Stock After Hours (Dec. 17, 2025): JNJ Closes Higher on FDA News—What to Know Before the Market Opens Thursday
Johnson & Johnson shares closed at $210.33 on Dec. 17, up on a day when major U.S. indexes fell. The company announced FDA approval for RYBREVANT FASPRO, a subcutaneous therapy for EGFR-mutated non-small cell lung cancer. After-hours trading edged shares to $210.48. Session volume was about 8.46 million shares.